statistics in vBulletin
  1. This site is not associated with any agent or consultant and colleges/universities. Views & Opinions expressed here are solely author's comment and Topuniversityforum.in is not responsible for them. Please don't make derogatory or abusive remarks against anyone.
  2. Prepare for GMAT, CAT, IIT, PMT & Other Entrance Exams. Post your questions and get answers. Collaborate, Learn & Grow.
    Dismiss Notice
  3. Hi Please download our Android App and enjoy the benefit of this forum on your smartphone. Download in Playstore
    Dismiss Notice
  4. Find Best Colleges in your Area, review them and share feedback.
    Dismiss Notice

Virtual Clinical Trial Service Providers Market is estimated to be worth USD 12 billion in 2050

Discussion in 'Business Analysis' started by Stella Wilson, Jul 5, 2021.

  1. Stella Wilson

    Stella Wilson New Member

    Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development.

    London

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Virtual Clinical Trial Service Providers Market, 2021-2050”

    The report features an extensive study of the current landscape of industry players that are offering various types of innovative clinical research platforms / solutions to the pharmaceutical and life sciences industries. Amongst other elements, the report features:

    · An overview of the current market landscape of companies offering solutions for virtual clinical trials, featuring information on year of establishment, geographical location, company size and types of services offered (study start-up, patient enrollment, drug logistics, data collection and analysis, and patient retention).

    · Brief profiles of companies offering solutions for virtual clinical trials, featuring information on their year of establishment, respective headquarters, company size, key executives, service / technology portfolio, recent developments and an informed future outlook.

    · A case study on the initiatives of big pharma players related to virtual clinical trials, offering insights on such clinical studies that have been conducted / planned by the aforementioned players, along with details on associated constraints and the future plans of players engaged in this domain.

    · An analysis of the funding and investments made in the domain, in the period between 2014 and 2020 (till November), including seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings, at various stages of development in companies that are engaged in this field, based on several parameters, such as number of funding instances, amount invested, type of funding, leading players and investors, and geographical analysis.

    · An analysis of the partnerships and collaborations inked in the domain, in the period between 2014 and 2020 (till November), based on several parameters, such as year of partnership, type of partnership, application mentioned in agreement, target therapeutic area mentioned in the agreement, type of partner, most active players and geographical analysis.

    · A detailed study highlighting the key differences between traditional and virtual CROs and an elaborate road map, presenting the requirements for a traditional CRO to transition to a virtual CRO business model.

    · A brief case study highlighting the impact of COVID-19 pandemic on virtual clinical trial service providers market.

    · A detailed analysis of completed, ongoing and planned virtual clinical trials, based on multiple parameters, such as trial registration year, trial phase, trial status, type of sponsor / collaborator, target therapeutic area, trial design, top sponsor, geographical location of trial and enrolled patient population.

    Request for Customization: https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market/request-customization.html

    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

    Therapeutic Area

    · Cardiovascular Disorders

    · CNS Disorders

    · Infectious Disorders

    · Metabolic Disorders

    · Oncological Disorders

    · Respiratory Disorders

    · Other Disorders

    Phase of Development

    · Phase I

    · Phase II

    · Phase III

    · Phase IV

    Key Geographical Regions

    · North America

    · Europe

    · Asia-Pacific

    · Rest of the World

    Key companies covered in the report

    · Cambridge Cognition

    · Center Point Clinical Services

    · eClinicalHealth

    · IQVIA

    · Mytrus (Medidata Solutions)

    · PanAmerican Clinical Research

    · Science 37

    · VirTrial

    Request for PDF Sample: https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market/request-sample.html

    Also have a Look on Our Upcoming Research Reports

    Soft Tissue Sarcoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031

    Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Trends and Global Forecasts, 2021-2030

    Spinal Muscular Atrophy Market, 2021-2031

    Dravet Syndrome Market, 2021-2031

    Hypertrophic Cardiomyopathy Market 2021-2031
     

Share This Page